Monte Rosa Therapeutics(GLUE) - 2024 Q4 - Earnings Call Transcript

Monte Rosa Therapeutic (GLUE) Q4 2024 Earnings Call March 20, 2025 01:22 PM ET Company Participants Andrew Funderburk - SVP, Head of Investor Relations & Strategic FinanceMarkus Warmuth - CEOFilip Janku - Chief Medical OfficerSharon Townson - Chief Scientific OfficerRobert Driscoll - SVP - Equity ResearchEllie Merle - ED - Biotech Equity ResearchEva Fortea-Verdejo - Vice President - Biotechnology Conference Call Participants Kelly Shi - SVP & Senior Research Analyst - BiotechnologyEdward Tenthoff - Sr. Rese ...